NCT04519541View on ClinicalTrials.gov

RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

September 11, 2022

Study Completion Date

January 31, 2023

Conditions
Facet Syndrome of Lumbar Spine
Interventions
DEVICE

Non-Invasive Thermal Ablation of the Medial Branch Nerves using the Neurolyser XR

Thermal ablation of the medial nerve branch using High Intensity Focused Ultrasound

Trial Locations (1)

Unknown

Rambam, Haifa

All Listed Sponsors
collaborator

Rambam

UNKNOWN

lead

FUSMobile Inc.

INDUSTRY

NCT04519541 - RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain | Biotech Hunter | Biotech Hunter